Galashiels, Scotland, 7th December, 2007 - ProStrakan Group plc (LSE: PSK), the
international specialty pharmaceutical company, announced on 30th October, 2007
that its co-founder and Chairman, Harry Stratford OBE, had informed the Board of
his intention to retire as Chairman at the end of 2007. The Company also
announced that Peter Allen, a Non-Executive Director since 2005, had accepted
the Board's invitation to replace him.
